13-14/10/17, Athens, Greece
Managing patients with impaired or poor ovarian response (POR) is a challenging issue. Number of oocytes retrieved has been adopted as a criterion of POR in most clinical trials, although the threshold number differs considerably between studies. A panel of experts (Patient-Oriented Strategies Encompassing Individualized Oocyte Number, the POSEIDON group) recently proposed new criteria to help guide the physician in handling POR patients.
This workshop will introduce the new POSEIDON criteria as a means to improve the management of patients exposed to assisted reproductive technologies, promote more specific approaches to patients with impaired prognosis during IVF, thereby offering better tools with which to optimize IVF success rates.
04-08/10/17, Antalya, Turkey
Reproductive Medicine Assisted Reproductive Technologies, Reproductive Genetics and Surgery are witnessing a significant expansion both clinically and in basic research. Obviously they will continue to undergo innovative and revolutionary changes in the forthcoming years, which may change our understanding and practice in the diagnosis and treatment of infertile couples. The information which will be accumulated in the near future especially in the field of stem cell research, molecular reproduction and human genetics may help our profession to be able to help more couples to have healthy babies.
Both Societies; International Society of Infertility and In Vitro Fertilization (ISIVF) and Society of Reproductive Medicine and Surgery (SRMS) are dedicated to the diagnosis and treatment of infertility and reproductive health including the promotion of science and research in all aspects of reproductive medicine and assisted reproductive technologies and human genetics, the understanding of evidence-based practices between clinicians and the enhancement of communication between scientists interested in these subjects worldwide.
28-30/09/17, Dubai, United Arab Emirates
On behalf of the executive committee, we are greatly honored and pleased to welcome you to attend the 24th Annual Meeting of the Middle East Fertility Society (MEFS) that will be held from September 28-30, 2017 in Grand Hyatt Dubai, UAE.
This year’s conference promises to be an exciting and rewarding one. A panel of highly distinguished international and local faculty speakers will offer the latest updates on the fields of human reproduction, fertility and infertility treatment, in addition to the high-standard presentations and lectures.
The MEFS annual meeting has traditionally become the meeting point where all fertility specialists across the Middle East find the opportunity to exchange scientific information, renew social bonds, strengthen national solidarity, and consolidate cultural heritage.
The host city, Dubai, is one of the most attractive touristic cities in the world, offering numerous attractions. You need not to be a professional diver to enjoy the city. there is an abundance of history to explore, a traditional cuisine to enjoy, an eyeful of breathtaking architecture here, and a good-natured haggle over a carpet there.
We offer you our warmest welcome and we look forward to count you among the conference participants, and I encourage you to register as soon as possible and make plans to join your colleagues and friends in Dubai to make the meeting a wonderful and memorable event.
Prof Marwan Alhalabi, MD PhD
President of the Middle East Fertility Society
15-17/09/17, Barcelona, Spain
The Congress focuses on Innovation in Preconception, Preimplantation and Prenatal Genetic Diagnosis, including:
- The use of Next Generation Sequencing for expanded preconception carrier screening
- Technology options for clinics with a review of strategies for evaluation of chromosome copy number in human embryos and oocytes
- Advances in Preimplantation Genetic Diagnosis (PGD) and the latest data on Preimplantation Genetic Screening (PGS)
- Non-invasive Prenatal Testing (NIPT) and Non-invasive Prenatal Diagnosis (NIPD)
- From Chromosomal Microarrays (CMA) to Whole Exome Sequencing (WES) in the evaluation of the malformed fetus Controversies in this burgeoning area of clinical practice
The CoGEN Congress is a part of the Virtual Academy of Genetics (VAoGEN), whose mission is to disseminate educational material on Reproductive Genetics to healthcare providers around the world and to provide a forum for the exchange of knowledge and ideas.
12/08/17, Sweden, Stockholm
The Nordic region’s first alternative parenting conference focused on best practice in surrogacy. Run by a committee of Swedish parents via surrogacy, sessions will cover the logistics, risks and practicalities of surrogacy in Ukraine, Greece, US and Canada for heterosexual and gay intended parents.
Speakers will include parents, IVF clinics, lawyers and surrogacy agency professionals.